Australian high-dose-rate brachytherapy protocols for gynaecological malignancy.
There is no consensus over the optimal dose fractionation schedules for high-dose-rate (HDR) brachytherapy used for gynaecological malignancy. In Australian public hospital departments of radiation oncology, HDR brachytherapy for gynaecological cancer is being more commonly used. A survey of public departments that are using this technology, or that plan to introduce this technology, was performed. Their current protocols are presented. In general, protocols are similar biologically; however, the practical aspects such as the number of fractions given do vary and may reflect resource restrictions or, alternatively, differences in interpretations of the literature and of the best protocols by clinicians.
MacLeod
C
C
Radiation Oncology, Murray Valley Hospital, Nordsvan Drive, Albury-Wodonga, Victoria, Australia. cmacleod@radoncvic.com.au
Cheuk
R
R
Dally
M
M
Fowler
A
A
Gauden
S
S
Leung
S
S
Milross
C
C
Narayan
K
K
Stevens
M
M
Thornton
D
D
Carruthers
S
S
Jeal
P
P
D001315:Australia; D001918:Brachytherapy; D002985:Clinical Protocols; D019583:Dose Fractionation, Radiation; D016889:Endometrial Neoplasms / Q000532:radiotherapy*; D005260:Female; D006801:Humans; D011879:Radiotherapy Dosage; D016896:Treatment Outcome; D002583:Uterine Cervical Neoplasms / Q000532:radiotherapy*